ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allspring Global Investments Holdings, LLC | 60 | $1,628 | 0.00% |
| Bell Investment Advisors, Inc | 13 | $353 | 0.00% |
| OSAIC HOLDINGS, INC. | 4,762 | $129,255 | 0.00% |
| FIRST TRUST ADVISORS LP | 14,947 | $405,661 | 0.00% |
| WELLS FARGO & COMPANY/MN | 14,581 | $395,716 | 0.00% |
| Pacer Advisors, Inc. | 4,060 | $110,188 | 0.00% |
| NewEdge Advisors, LLC | 0 | $0 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 3,500 | $94,990 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 5,509 | $149,514 | 0.00% |
| IFP Advisors, Inc | 84 | $2,289 | 0.00% |
| HUNTINGTON NATIONAL BANK | 261 | $7,084 | 0.00% |
| HighTower Advisors, LLC | 10 | $2 | 0.00% |
| Spire Wealth Management | 450 | $12,213 | 0.00% |
| Allworth Financial LP | 953 | $25,865 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 40,900 | $1,110,026 | 0.00% |
| NORTHWEST INVESTMENT COUNSELORS, LLC | 0 | $0 | 0.00% |
| Citadel Advisors | 69,800 | $1,894,372 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 71 | $1,927 | 0.00% |
| US BANCORP \DE\ | 3,760 | $102,059 | 0.00% |
| LOOMIS SAYLES & CO L P | 301 | $8 | 0.00% |
External links
This page lists ROYALTY PHARMA PLC's shareholders in Q3 2023. To view ROYALTY PHARMA PLC's shareholder history, click here.